Sona Nanotech Inc
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests. Sona Nanotech Inc. is based in Halifax, Canada.
Sona Nanotech Inc (SNANF) - Total Liabilities
Latest total liabilities as of April 2025: $1.28 Million USD
Based on the latest financial reports, Sona Nanotech Inc (SNANF) has total liabilities worth $1.28 Million USD as of April 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sona Nanotech Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how Sona Nanotech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sona Nanotech Inc Competitors by Total Liabilities
The table below lists competitors of Sona Nanotech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Barfresh Food Group Inc
NASDAQ:BRFH
|
USA | $4.87 Million |
|
Plenitude Bhd
KLSE:5075
|
Malaysia | RM771.64 Million |
|
Shivalik Rasayan Limited
NSE:SHIVALIK
|
India | ₹2.18 Billion |
|
Teads B.V.
NASDAQ:TEAD
|
USA | $1.19 Billion |
|
SGC eTEC E&C Co. Ltd
KQ:016250
|
Korea | ₩987.40 Billion |
|
Aegis Brands Inc
PINK:SCUPF
|
USA | $31.73 Million |
|
Yong Shun Chemical Co Ltd
TWO:4711
|
Taiwan | NT$195.14 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Sona Nanotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sona Nanotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sona Nanotech Inc (2016–2024)
The table below shows the annual total liabilities of Sona Nanotech Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-10-31 | $1.24 Million | -22.02% |
| 2023-10-31 | $1.59 Million | +54.21% |
| 2022-10-31 | $1.03 Million | -62.55% |
| 2021-10-31 | $2.75 Million | -33.98% |
| 2020-10-31 | $4.16 Million | +121.09% |
| 2019-10-31 | $1.88 Million | -36.83% |
| 2018-10-31 | $2.98 Million | +74.09% |
| 2017-10-31 | $1.71 Million | -21.30% |
| 2016-10-31 | $2.17 Million | -- |